Figure 1.
Pattern of CMV viremia in the first 180 days post-CBT in recipients of letermovir prophylaxis. Patients are listed in chronological order. One patient discontinued letermovir upon initiation of foscarnet on day 36 for human herpesvirus 6 pneumonia. One patient with adenovirus infection also received cidofovir from day 23.

Pattern of CMV viremia in the first 180 days post-CBT in recipients of letermovir prophylaxis. Patients are listed in chronological order. One patient discontinued letermovir upon initiation of foscarnet on day 36 for human herpesvirus 6 pneumonia. One patient with adenovirus infection also received cidofovir from day 23.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal